• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用多重聚合酶链反应/异源双链分析检测皮肤T细胞淋巴瘤(蕈样肉芽肿/ Sézary综合征)和良性炎症性疾病患者的T细胞受体γ基因重排:与临床、组织学和免疫表型结果的相关性

T-cell receptor gamma gene rearrangement by multiplex polymerase chain reaction/heteroduplex analysis in patients with cutaneous T-cell lymphoma (mycosis fungoides/Sézary syndrome) and benign inflammatory disease: correlation with clinical, histological and immunophenotypical findings.

作者信息

Ponti R, Quaglino P, Novelli M, Fierro M T, Comessatti A, Peroni A, Bonello L, Bernengo M G

机构信息

Section of Dermatology, Department of Biomedical Sciences and Human Oncology, University of Turin, Via Cherasco 23, 10126, Torino, Italy.

出版信息

Br J Dermatol. 2005 Sep;153(3):565-73. doi: 10.1111/j.1365-2133.2005.06649.x.

DOI:10.1111/j.1365-2133.2005.06649.x
PMID:16120144
Abstract

BACKGROUND

A dominant T-cell clone can be detected by polymerase chain reaction (PCR) in 40-90% of cutaneous samples from patients with cutaneous T-cell lymphoma (CTCL).

MATERIALS AND METHODS

From 1996 to 2003 we analysed 547 cutaneous biopsies performed to exclude CTCL (mycosis fungoides, MF/Sézary syndrome, SS). The final diagnosis was benign inflammatory disease (BID) in 353 samples (64.5%) and CTCL in 194 (35.5%). T-cell receptor (TCR)-gamma gene rearrangement was studied by using a multiplex PCR/heteroduplex (HD) analysis. The PCR results were correlated with the clinical picture, the histological pattern and the presence of T-cell lineage antigen loss, using univariate and multivariate logistic regression analyses.

OBJECTIVE

To determine the sensitivity and specificity of the multiplex PCR/HD analysis and to identify which are the clinical, histopathological or immunophenotypical features significantly associated with a positive T-cell clonality.

RESULTS

A clonality was demonstrated in 83.5% of CTCL and in 2.3% of BID (P < 0.001). A significantly higher percentage of clonal cases was associated with the cutaneous T-score (71.4% in T1, 76.1% in T2 and 100% in nodular and erythrodermic MF samples) and with the presence of a T-cell lineage antigen loss (93.9% vs. 77.4%). Moreover, clonality was closely related to an increase in the histopathological score (51.3% in the samples with a score < 5, compared with 92% in the lesions with > or = 5). No significant difference in the percentage of clonal cases was found between T1/T2 and T3/T4 lesions with a histopathological score > or = 5. The multivariate logistic regression showed that the density and extent of the cell infiltrate, the degree of epidermotropism and the presence of cytological atypia share an independent predictive value for clonality in T1/T2 samples, even if the highest odds ratios (3.6) were associated with the density of the cell infiltrate. The disease course of T1/T2 patients was analysed according to the PCR findings. All the PCR-negative patients showed a long-standing stable disease course; on the other hand, a disease progression occurred in 12/87 (13.8%) positive patients.

CONCLUSIONS

The multiplex PCR/HD analysis is associated with a high diagnostic accuracy (92.7%) in CTCL patients. The finding of a clonal T-cell rearrangement is more closely associated with the histological pattern (in particular with the density and extent of the cell infiltrate) rather than with the MF cutaneous T-score or immunophenotype.

摘要

背景

在皮肤T细胞淋巴瘤(CTCL)患者的皮肤样本中,40% - 90%可通过聚合酶链反应(PCR)检测到优势T细胞克隆。

材料与方法

1996年至2003年,我们分析了547例为排除CTCL(蕈样肉芽肿,MF/ Sézary综合征,SS)而进行的皮肤活检。最终诊断为良性炎症性疾病(BID)的有353例(64.5%),CTCL的有194例(35.5%)。采用多重PCR/异源双链(HD)分析研究T细胞受体(TCR)-γ基因重排。使用单因素和多因素逻辑回归分析,将PCR结果与临床表现、组织学模式以及T细胞谱系抗原丢失情况相关联。

目的

确定多重PCR/HD分析的敏感性和特异性,并确定哪些临床、组织病理学或免疫表型特征与T细胞克隆性阳性显著相关。

结果

83.5%的CTCL和2.3%的BID显示有克隆性(P < 0.001)。克隆性病例的百分比显著更高与皮肤T评分相关(T1中为71.4%,T2中为76.1%,结节性和红皮病型MF样本中为100%)以及与T细胞谱系抗原丢失的存在相关(93.9%对77.4%)。此外,克隆性与组织病理学评分的增加密切相关(评分<5的样本中为51.3%,而评分≥5的病变中为92%)。组织病理学评分≥5的T1/T2和T3/T4病变之间克隆性病例的百分比无显著差异。多因素逻辑回归显示,细胞浸润的密度和范围、亲表皮程度以及细胞异型性的存在对T1/T2样本中的克隆性具有独立的预测价值,即使最高比值比(3.6)与细胞浸润的密度相关。根据PCR结果分析了T1/T2患者的病程。所有PCR阴性患者显示病程长期稳定;另一方面,12/87例(13.8%)阳性患者出现疾病进展。

结论

多重PCR/HD分析在CTCL患者中具有较高的诊断准确性(92.7%)。克隆性T细胞重排的发现与组织学模式(特别是与细胞浸润的密度和范围)的相关性比与MF皮肤T评分或免疫表型的相关性更密切。

相似文献

1
T-cell receptor gamma gene rearrangement by multiplex polymerase chain reaction/heteroduplex analysis in patients with cutaneous T-cell lymphoma (mycosis fungoides/Sézary syndrome) and benign inflammatory disease: correlation with clinical, histological and immunophenotypical findings.采用多重聚合酶链反应/异源双链分析检测皮肤T细胞淋巴瘤(蕈样肉芽肿/ Sézary综合征)和良性炎症性疾病患者的T细胞受体γ基因重排:与临床、组织学和免疫表型结果的相关性
Br J Dermatol. 2005 Sep;153(3):565-73. doi: 10.1111/j.1365-2133.2005.06649.x.
2
Detection of clonal T-cell receptor gamma gene rearrangements with the use of the polymerase chain reaction in cutaneous lesions of mycosis fungoides and Sézary syndrome.利用聚合酶链反应检测蕈样肉芽肿和塞扎里综合征皮肤病变中的克隆性T细胞受体γ基因重排。
Arch Dermatol. 1995 Sep;131(9):1027-31.
3
Molecular staging of lymph nodes from 60 patients with mycosis fungoides and Sézary syndrome: correlation with histopathology and outcome suggests prognostic relevance in mycosis fungoides.60例蕈样肉芽肿和塞扎里综合征患者淋巴结的分子分期:与组织病理学及预后的相关性提示其在蕈样肉芽肿中具有预后意义。
Br J Dermatol. 2006 Oct;155(4):756-62. doi: 10.1111/j.1365-2133.2006.07428.x.
4
Clonal T cell receptor gamma-chain gene rearrangement by PCR-based GeneScan analysis in the skin and blood of patients with parapsoriasis and early-stage mycosis fungoides.通过基于聚合酶链反应(PCR)的基因扫描分析检测副银屑病和早期蕈样肉芽肿患者皮肤及血液中的克隆性T细胞受体γ链基因重排。
J Pathol. 2002 Jul;197(3):348-54. doi: 10.1002/path.1133.
5
Genotypic analysis of cutaneous T-cell lymphoma: a comparative study of Southern blot analysis with polymerase chain reaction amplification of the T-cell receptor-gamma gene.皮肤T细胞淋巴瘤的基因分型分析:Southern印迹分析与T细胞受体γ基因聚合酶链反应扩增的比较研究
Br J Dermatol. 1997 Nov;137(5):673-9.
6
Value of clonality studies of cutaneous T lymphocytes in the diagnosis and follow-up of patients with mycosis fungoides.皮肤T淋巴细胞克隆性研究在蕈样肉芽肿患者诊断及随访中的价值
J Pathol. 1998 Feb;184(2):185-90. doi: 10.1002/(SICI)1096-9896(199802)184:2<185::AID-PATH997>3.0.CO;2-9.
7
Cytologic evaluation of lymphadenopathy associated with mycosis fungoides and Sezary syndrome: role of immunophenotypic and molecular ancillary studies.蕈样肉芽肿和塞扎里综合征相关淋巴结病的细胞学评估:免疫表型和分子辅助研究的作用
Cancer. 2008 Oct 25;114(5):323-32. doi: 10.1002/cncr.23793.
8
Improved sensitivity of T-cell clonality detection in mycosis fungoides by hand microdissection and heteroduplex analysis.通过手工显微切割和异源双链分析提高蕈样肉芽肿中T细胞克隆性检测的敏感性。
Arch Dermatol. 2003 Dec;139(12):1571-5. doi: 10.1001/archderm.139.12.1571.
9
T-cell clonality analysis in biopsy specimens from two different skin sites shows high specificity in the diagnosis of patients with suggested mycosis fungoides.对来自两个不同皮肤部位的活检标本进行T细胞克隆性分析,在诊断疑似蕈样肉芽肿患者时具有高度特异性。
J Am Acad Dermatol. 2007 Nov;57(5):782-90. doi: 10.1016/j.jaad.2007.06.004. Epub 2007 Jul 23.
10
The usefulness of clonality for the detection of cases clinically and/or histopathologically not recognized as cutaneous T-cell lymphoma.克隆性在检测临床上和/或组织病理学上未被识别为皮肤T细胞淋巴瘤的病例中的实用性。
Br J Dermatol. 2005 Aug;153(2):368-71. doi: 10.1111/j.1365-2133.2005.06760.x.

引用本文的文献

1
Mycosis Fungoides, Sézary Syndrome, and Cutaneous B-Cell Lymphomas: 2025 Update on Diagnosis, Risk-Stratification, and Management.蕈样肉芽肿、塞扎里综合征和皮肤B细胞淋巴瘤:2025年诊断、风险分层及管理的最新进展
Am J Hematol. 2025 Sep;100(9):1603-1628. doi: 10.1002/ajh.27735. Epub 2025 Jun 10.
2
Immunosequencing applications in cutaneous T-cell lymphoma.免疫测序在皮肤 T 细胞淋巴瘤中的应用。
Front Immunol. 2023 Dec 21;14:1300061. doi: 10.3389/fimmu.2023.1300061. eCollection 2023.
3
Paediatric Mycosis Fungoides: Clinical Variants, Treatment Modalities and Response to Therapy.
儿童蕈样肉芽肿:临床变异型、治疗方式和治疗反应。
Acta Derm Venereol. 2023 Jul 14;103:adv6557. doi: 10.2340/actadv.v103.6557.
4
Mycosis fungoides and Sézary syndrome.蕈样肉芽肿和塞扎里综合征。
Blood Res. 2023 Apr 30;58(S1):66-82. doi: 10.5045/br.2023.2023023.
5
Cutaneous T-cell lymphomas: 2023 update on diagnosis, risk-stratification, and management.皮肤 T 细胞淋巴瘤:2023 年诊断、风险分层和治疗更新。
Am J Hematol. 2023 Jan;98(1):193-209. doi: 10.1002/ajh.26760. Epub 2022 Oct 20.
6
Cutaneous T-cell lymphomas: 2021 update on diagnosis, risk-stratification, and management.皮肤 T 细胞淋巴瘤:2021 年诊断、风险分层和治疗更新。
Am J Hematol. 2021 Oct 1;96(10):1313-1328. doi: 10.1002/ajh.26299. Epub 2021 Aug 2.
7
Diagnostic Value of Genotypic Analysis in Primary Cutaneous Lymphomas using Standardized BIOMED-2 Polymerase Chain Reaction Protocols: Experience in Daily Clinical Practice.基于标准化 BIOMED-2 聚合酶链反应方案的原发性皮肤淋巴瘤基因分析的诊断价值:日常临床实践经验。
Acta Derm Venereol. 2021 May 19;101(5):adv00460. doi: 10.2340/00015555-3828.
8
Recent advances in understanding and managing cutaneous T-cell lymphomas.皮肤T细胞淋巴瘤的认识与管理的最新进展
F1000Res. 2020 May 5;9. doi: 10.12688/f1000research.21922.1. eCollection 2020.
9
An Update on Molecular Biology of Cutaneous T Cell Lymphoma.皮肤T细胞淋巴瘤分子生物学的最新进展
Front Oncol. 2020 Jan 22;9:1558. doi: 10.3389/fonc.2019.01558. eCollection 2019.
10
Next-Generation Sequencing Technologies for Early-Stage Cutaneous T-Cell Lymphoma.用于早期皮肤T细胞淋巴瘤的新一代测序技术
Front Med (Lausanne). 2019 Aug 13;6:181. doi: 10.3389/fmed.2019.00181. eCollection 2019.